Docket Room.
HB 1477·MD·house

Public Health - Ibogaine Clinical Research Grant Program - Establishment (Veterans Mental Health Innovations Act)

FailedFiled Feb 13, 2026
Sponsor: Odom
Latest Action

Hearing (House)

Mar 10, 2026

Email me when HB 1477 moves

Committee action, floor votes, amendments and hearings. Free, no card, no password.

Already have an account? Track HB 1477. By continuing you agree to the Terms and Privacy Policy.

Summary

The bill would establish the Ibogaine Clinical Research Grant Program, allowing up to three Maryland research institutions each year to receive matching grants for FDA‑overseen clinical trials of ibogaine to treat opioid use disorder and other neurological conditions. Funding of $500,000 per fiscal year (2028‑2030) would come from the Opioid Restitution Fund, and the program would be administered by the Department of Health in consultation with the Department of Veterans and Military Families. The measure failed to pass.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Ask about HB 1477

3 free questions a day, no account

Hearings

History

  1. Hearing 3/10 at 1:00 p.m.
  2. First Reading Health

Sponsors

  • Odom · sponsor
  • Behler
  • Boafo
  • Fennell
  • Holmes
  • J. Long
  • Lehman
  • Phillips
  • Rogers
  • Simmons

Bill text

Read the official text ↗

Opens the legislature’s own copy.

Similar bills in other states

Loading the map of where bills like this one were filed.

Share

Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.

Track this bill

Get an email when HB 1477 moves: committee action, floor votes, amendments and hearings. Free, no card.

Track HB 1477 free

Or ask your AI assistant about HB 1477 directly:

Add to Claude, ChatGPT or Cursor
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice